4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-22-000049
EVP Chief Technology Officer returned 4,273 shares (to the company)
- EVP Chief Technology Officer acquired 6,741 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Leach Jacob Steven EVP Chief Technology Officer | 2022-03-08 | Grant or award | +6,741 | $0.00 | $7 | 79,019 | D: show line 1 in the form |
| Leach Jacob Steven EVP Chief Technology Officer | 2022-03-09 | Returned to the company | −1,317 | $406.06 | $534,777 | 77,702 | D: show line 2 in the form |
| Leach Jacob Steven EVP Chief Technology Officer | 2022-03-09 | Returned to the company | −2,065 | $406.06 | $838,507 | 75,637 | D: show line 3 in the form |
| Leach Jacob Steven EVP Chief Technology Officer | 2022-03-09 | Returned to the company | −891 | $406.06 | $361,797 | 74,746 | D: show line 4 in the form |
Loading xslF345X03/edgardoc.xml…